Literature DB >> 15684039

CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production.

Thomas Barthlott1, Halima Moncrieffe, Marc Veldhoen, Christopher J Atkins, Jillian Christensen, Anne O'Garra, Brigitta Stockinger.   

Abstract

Maintenance of homeostasis in the immune system involves competition for resources between T lymphocytes, which avoids the development of immune pathology seen in lymphopenic mice. CD25+ CD4+ T cells are important for homeostasis, but there is as yet no consensus on their mechanisms of action. Although CD25+ CD4+ T cells cause substantial down-regulation of IL-2 mRNA in responder T cells in an in vitro co-culture system, the presence of IL-protein can be demonstrated by intracellular staining. As a consequence of competition for IL-2, CD25+ CD4+ T cells further up-regulate the IL-2R alpha chain (CD25), a process that is strictly dependent on IL-2, whereas responder T cells fail to up-regulate CD25. Similarly, adoptive transfer into lymphopenic mice showed that CD25+ CD4+ T cells interfere with CD25 up-regulation on co-transferred naive T cells, while increasing their own CD25 levels. IL-2 sequestration by CD25+ CD4+ T cells is not a passive phenomenon but instead initiates--in conjunction with signals through the TCR--their differentiation to IL-10 production. Although IL-10 is not required for in vitro suppression, it is vital for the in vivo function of regulatory T cells. Our data provide a link explaining the apparent difference in regulatory mechanisms in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15684039     DOI: 10.1093/intimm/dxh207

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  65 in total

1.  Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T cells.

Authors:  Shuai Tang; Miranda L Moore; Jason M Grayson; Purnima Dubey
Journal:  Cancer Res       Date:  2012-02-28       Impact factor: 12.701

Review 2.  Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases.

Authors:  N Beyersdorf; T Hanke; T Kerkau; T Hünig
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

3.  Interleukin-2-dependent mechanisms of tolerance and immunity in vivo.

Authors:  Paul A Antony; Chrystal M Paulos; Mojgan Ahmadzadeh; Akgül Akpinarli; Douglas C Palmer; Noriko Sato; Andrew Kaiser; Christian S Hinrichs; Christian Heinrichs; Christopher A Klebanoff; Yutaka Tagaya; Nicholas P Restifo
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

Review 4.  Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target.

Authors:  Dorothy K Sojka; Yu-Hui Huang; Deborah J Fowell
Journal:  Immunology       Date:  2008-03-14       Impact factor: 7.397

5.  Expansion of CD4+CD25+ suppressive regulatory T cells from rhesus macaque peripheral blood by FN18/antihuman CD28-coated Dynal beads.

Authors:  Balgansuren Gansuvd; Clement K Asiedu; Jeanine Goodwin; Uuganbayar Jargal; Lindsey A Deckard; Patricio Andrades; Vincenzo Guarcello; Judith M Thomas
Journal:  Hum Immunol       Date:  2007-04-02       Impact factor: 2.850

Review 6.  MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development.

Authors:  Katie Podshivalova; Daniel R Salomon
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

7.  The epigenetic regulator Uhrf1 facilitates the proliferation and maturation of colonic regulatory T cells.

Authors:  Yuuki Obata; Yukihiro Furusawa; Takaho A Endo; Jafar Sharif; Daisuke Takahashi; Koji Atarashi; Manabu Nakayama; Satoshi Onawa; Yumiko Fujimura; Masumi Takahashi; Tomokatsu Ikawa; Takeshi Otsubo; Yuki I Kawamura; Taeko Dohi; Shoji Tajima; Hiroshi Masumoto; Osamu Ohara; Kenya Honda; Shohei Hori; Hiroshi Ohno; Haruhiko Koseki; Koji Hase
Journal:  Nat Immunol       Date:  2014-04-28       Impact factor: 25.606

8.  Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP.

Authors:  Renata Mazzucchelli; Julie A Hixon; Rosanne Spolski; Xin Chen; Wen Qing Li; Veronica L Hall; Jami Willette-Brown; Arthur A Hurwitz; Warren J Leonard; Scott K Durum
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

9.  Prevention and treatment of experimental autoimmune encephalomyelitis with clonotypic CDR3 peptides: CD4(+) Foxp3(+) T-regulatory cells suppress interleukin-2-dependent expansion of myelin basic protein-specific T cells.

Authors:  Abigail C Buenafe; Shayne Andrew; Michael Afentoulis; Halina Offner; Arthur A Vandenbark
Journal:  Immunology       Date:  2010-01-06       Impact factor: 7.397

10.  Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice.

Authors:  Tea Gogishvili; Daniela Langenhorst; Fred Lühder; Fernando Elias; Karin Elflein; Kevin M Dennehy; Ralf Gold; Thomas Hünig
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.